13G INITIAL ANNUAL FILING - (ITEK)

Company

ROCKET PHARMACEUTICALS, INC.

Filed

February 3, 2016

Accession Number

0000053417-16-000214

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →